Received Jul 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
autoimmune disease: myasthenia gravis; This is a spontaneous report received from a Consumer or other non HCP. A 40-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Dec2021 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 39 years for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed; unknown manufacturer), for COVID-19 immunisation. The following information was reported: MYASTHENIA GRAVIS (caused and prolonged hospitalization, disability, medically significant) with onset 16Jan2022, outcome "not recovered", described as "autoimmune disease: myasthenia gravis". Soon after the booster shot, patient started feeling symptoms of her autoimmune disease myasthenia gravis. She was never even sick before she got the vaccines The patient was hospitalized and prolonged hospitalization for myasthenia gravis (hospitalization duration: 3 day(s)). Therapeutic measures were taken as a result of myasthenia gravis (prescription for myasthenia gravis). The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none